4528.T JPX
Ono Pharmaceutical Co., Ltd.
1W: -4.6%
1M: -6.5%
3M: -4.1%
YTD: -10.1%
1Y: +36.1%
3Y: -0.2%
5Y: +5.2%
¥2,278.50 ($14.46)
-11.50 (-0.50%)
Weekly Expected Move ±2.9%
¥2157
¥2224
¥2290
¥2356
¥2423
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$136.8B
+65.9% ▲
5Y CAGR: +13.1%
Capital Expenditures
$6.0B
-10.9% ▼
5Y CAGR: -21.6%
Free Cash Flow
$130.8B
+69.8% ▲
5Y CAGR: +19.5%
Dividends Paid
$37.5B
-0.0% ▼
Buybacks
$1M
+0.0% ▲
Net Change in Cash
$32.5B
-15.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $105.0B | $143.5B | $128.0B | $50.0B | $69.8B |
| Depreciation & Amort. | $17.7B | $17.5B | $18.1B | $26.9B | $37.8B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$30.1B | $1.4B | -$29.0B | $33.5B | $21.5B |
| Other Non-Cash Items | -$30.8B | -$2.8B | -$6.5B | -$27.9B | $7.8B |
| Operating Cash Flow | $61.8B | $159.6B | $110.7B | $82.5B | $136.8B |
| — Investing Activities — | |||||
| Capital Expenditures | -$12.3B | -$14.5B | -$4.0B | -$8.0B | -$53.3B |
| Acquisitions (Net) | -$6.8B | -$9.2B | $0 | -$364.8B | $21M |
| Investment Purchases | -$58.6B | -$140.6B | -$36.7B | -$4.1B | -$4.4B |
| Investment Sales | $78.6B | $55.9B | $106.0B | $240.8B | $18.7B |
| Other Investing | $5.1B | $8.1B | -$17.2B | -$752M | -$844M |
| Investing Cash Flow | $6.0B | -$100.3B | $48.1B | -$136.8B | -$39.9B |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $135.0B | -$24.6B |
| Stock Repurchased | -$30.0B | -$1M | -$50.0B | -$1M | -$1M |
| Dividends Paid | -$27.7B | -$29.7B | -$37.2B | -$37.5B | -$37.5B |
| Other Financing | -$2.6B | -$2.7B | -$2.7B | -$3.2B | -$3.3B |
| Financing Cash Flow | -$60.2B | -$32.5B | -$89.8B | $94.3B | -$65.5B |
| Net Change in Cash | $8.1B | $27.0B | $70.0B | $38.4B | $32.5B |
| Cash End of Period | $69.1B | $96.1B | $166.1B | $204.6B | $237.0B |
| Free Cash Flow | $49.6B | $145.1B | $89.8B | $77.0B | $130.8B |